Pasithea Therapeutics Corp. (KTTA)

USD 1.4

(-7.89%)

Market Cap (In USD)

3.78 Million

Revenue (In USD)

-

Net Income (In USD)

-15.96 Million

Avg. Volume

2.79 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.52-9.4
PE
-0.11
EPS
-12.69
Beta Value
0.821
ISIN
US70261F2020
CUSIP
70261F103
CIK
1841330
Shares
2705263.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Tiago Reis Marques M.D., Ph.D.
Employee Count
-
Website
https://www.pasithea.com
Ipo Date
2021-09-15
Details
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.